Sort
16,179 grants matching “malaria”
Toxoplasma Rhoptry Function
$477,659John C Boothroyd · Stanford University · R01 · FY2013 · AI
CD8 T cell and B cell collaboration following subunit vaccination
$477,558Ross M Kedl · University Of Colorado Denver · R01 · FY2023 · AI
Impact of Environmental Modifications on Plasmodium falciparum and P. vivax Malaria Epidemiology and Disease Burden
$477,492Beyene Petros · University Of California-Irvine · U19 · FY2019 · AI
Mechanisms Governing Translational Regulation During Plasmodium Transmission
$477,453Scott E Lindner · Pennsylvania State University, The · R56 · FY2022 · AI
Immunologic Assays to Assess Malaria Exposure and Protection
$477,011Harriet Mayanja-Kizza · University Of California, San Francisco · U19 · FY2013 · AI
Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease
$477,000Jishnu Das · University Of Pittsburgh At Pittsburgh · DP2 · FY2022 · AI
Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease
$477,000Jishnu Das · University Of Pittsburgh At Pittsburgh · DP2 · FY2024 · AI
Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease
$477,000Jishnu Das · University Of Pittsburgh At Pittsburgh · DP2 · FY2023 · AI
Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease
$477,000Jishnu Das · University Of Pittsburgh At Pittsburgh · DP2 · FY2025 · AI
Dual Function Acridones as A New Antimalarial Chemotype
$476,966Jane X Kelly · Portland State University · RC1 · FY2009 · AI
Variant surface antigens in cerebral malaria pathogenesis
$476,891Christopher V. Plowe · University Of Maryland Baltimore · R01 · FY2015 · HL
PAPUA NEW GUINEAN DUFFY NEGATIVITY AND VIVAX MALARIA
$476,838Case Western Reserve University · R01 · FY2004 · AI
Identification of CYP5122A1 inhibitors as chemical probes for Leishmania biology
$476,805Zhuo Michael Wang · University Of Kansas Lawrence · R01 · FY2022 · AI
Human-informed data-driven development of next-generation T cell vaccine against malaria
$476,538Denise L. Doolan · University Of Queensland · R01 · FY2024 · AI
Immunogenicity of Synthetic Peptide Malaria Vaccines
$476,477Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2007 · AI
A Chemical Vaccine for Malaria
$476,454Theresa A Shapiro · Johns Hopkins University · R01 · FY2020 · AI
Molecular Mechanisms Underlying Insect Odorant Receptor Function and Modulation
$476,405Vanessa Ruta · Rockefeller University · R01 · FY2023 · AI
Discovery, Design, and Development of Phosphonic Acid Antibiotics
$476,276William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2009 · GM
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria
$476,152James Walter Kazura · University Of California-Irvine · U19 · FY2020 · AI
Immune responses to HIV virus immunization - Project 2
$475,999Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2018 · AI
Phenotypic Assay Design and Development for Rare and Neglected Diseases
$475,656James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Epidemiological and Spatial Models of Malaria Transmission
$475,541Steven Richard Meshnick · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
Phase II Environmentally greener, efficient, and safe synthetic platform for the
$475,412Paul Matthew Herrinton · Boropharm, Inc. · R44 · FY2011 · GM
Impact of Mass Drug Administration with or Without Insecticide Impregnated Nets
$475,051James Walter Kazura · Case Western Reserve University · U19 · FY2008 · AI
Study type 3: A cluster randomized trial to evaluate the impact of malaria control interventions on measures of malaria incidence
$475,019Moses Robert Kamya · University Of California, San Francisco · U19 · FY2019 · AI